Phase I/II Trial of Ruxolitinib in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer
暂无分享，去创建一个
Shing M. Lee | A. Califano | Jose M. Silva | P. Klein | D. Hershman | E. Andreopoulou | D. Makower | K. Kalinsky | A. Goel | M. Trivedi | Dow-Chung Chi | M. Accordino | T. Cigler | Matthew Kearney | A. Tiersten | J. Sparano | P. Mundi | Lauren E. Franks | Matthew R. Kearney